Matias de Juan

Luiz Luccas

Robert DiMarzo

Mehdi Mehdi

Benjamin Lee

Dr. Peter Loskill

Dr. Peter Loskill is Assistant Professor for Experimental Regenerative Medicine at the Eberhard Karls University Tübingen and head of the Fraunhofer Attract group Organ-on-a-Chip at the Fraunhofer Institute for Interfacial Engineering and Biotechnology (IGB) in Stuttgart, Germany. Dr. Loskill graduated in 2012 from Saarland University with a PhD in Physics focusing on Biointerface science.

Blythe Jack

Blythe is responsible for originating new investment opportunities, diligencing new business opportunities, structuring transactions and working with our partner companies. She is also a member of the Investment Committee.

Blythe joined TSG with extensive private equity and branded consumer experience, having spent over 10 years at Rosewood Capital and having served as CEO of a high-growth consumer products company. While a partner at Rosewood Capital, Blythe sourced and structured investments across the consumer & retail sector, including investments in Under Armour, Clarisonic, Sneaker Villa, Cobalt Boats, among others. She has also served as a National Judge for Ernst & Young's acclaimed Entrepreneur of the Year® program. Blythe received a BA, with honors, in Communication Studies from Vanderbilt University.

Olivier Garel

M&A professional, Olivier has led a large number of transformative acquisition and divestment transactions for Unilever in different parts of the world. Over the last 20 years in Unilever, he has held senior positions in finance, strategy and business development. Olivier leads Unilever Ventures Investment Committee and manages relationships with a number of Corporate and Venture Capital funds and Private Equity funds around the world. He is currently a Board Director of Iluminage Beauty, Yummly, REN and ioma.